AIMOVIG
These highlights do not include all the information needed to use AIMOVIG safely and effectively. See full prescribing information for AIMOVIG. AIMOVIG (erenumab-aooe) injection, for subcutaneous use Initial U.S. Approval: 2018
b998ed05-94b0-47fd-b28f-cddd1e128fd8
HUMAN PRESCRIPTION DRUG LABEL
May 16, 2023
Amgen Inc
DUNS: 039976196
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
erenumab-aooe
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (4)
erenumab-aooe
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (4)
erenumab-aooe
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (4)
erenumab-aooe
Product Details
FDA regulatory identification and product classification information